Cargando…

Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters

The mixture of Salvia miltiorrhiza and Carthamus tinctorius (Danhong injection, DHI) is widely prescribed in China for the treatment of cardiovascular and cerebrovascular diseases. In most cases, DHI is used in combination with acetylsalicylic acid (aspirin, ASA). However, the interaction between DH...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianping, Lu, Jingbo, Peng, Yin, Xu, Xuejun, Chen, Chenkai, Gao, Ming, Lin, Ling, Guo, Jianming, Duan, Jinao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562828/
https://www.ncbi.nlm.nih.gov/pubmed/33132911
http://dx.doi.org/10.3389/fphar.2020.577012
_version_ 1783595357117087744
author Li, Jianping
Lu, Jingbo
Peng, Yin
Xu, Xuejun
Chen, Chenkai
Gao, Ming
Lin, Ling
Guo, Jianming
Duan, Jinao
author_facet Li, Jianping
Lu, Jingbo
Peng, Yin
Xu, Xuejun
Chen, Chenkai
Gao, Ming
Lin, Ling
Guo, Jianming
Duan, Jinao
author_sort Li, Jianping
collection PubMed
description The mixture of Salvia miltiorrhiza and Carthamus tinctorius (Danhong injection, DHI) is widely prescribed in China for the treatment of cardiovascular and cerebrovascular diseases. In most cases, DHI is used in combination with acetylsalicylic acid (aspirin, ASA). However, the interaction between DHI and ASA remains largely undefined. The purpose of this study is to explore the interaction profile and mechanism between DHI and ASA. The frequency of drug combination of DHI and ASA was analyzed based on 5,183 clinical cases. The interaction characteristics were evaluated by analyzing the pharmacokinetics and disposition profile of salicylic acid (SA, the primary metabolite of ASA) in rats. The interaction mechanisms were explored through evaluating the hydrolysis of ASA regulated by ASA esterase, the tubular secretion of SA mediated by influx and efflux transporters, and the tubular reabsorption of SA regulated by urinary acidity-alkalinity. The inhibitory potential of DHI on organic anion transporters (OATs) was further verified in aristolochic acid I (AAI) induced nephropathy. Clinical cases analysis showed that DHI and ASA were used in combination with high frequency of 70.73%. In drug combination of DHI and ASA, the maximum plasma concentration of SA was significantly increased by 1.37 times, while the renal excretion of SA was significantly decreased by 32.54%. The mechanism study showed that DHI significantly inhibited the transport function, gene transcription and protein expression of OATs. In OATs mediated AAI nephropathy, DHI significantly reduced the renal accumulation of AAI by 55.27%, and alleviated renal damage such as glomerulus swelling, tubular blockage and lymphocyte filtration. In drug combination of DHI and ASA, DHI increased the plasma concentration of SA not through enhancing the hydrolysis of ASA, and the tubular reabsorption of SA was not significantly affected. Inhibition of tubular secretion of SA mediated by OATs might be the reason that contributes to the decrease of SA renal excretion.
format Online
Article
Text
id pubmed-7562828
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75628282020-10-29 Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters Li, Jianping Lu, Jingbo Peng, Yin Xu, Xuejun Chen, Chenkai Gao, Ming Lin, Ling Guo, Jianming Duan, Jinao Front Pharmacol Pharmacology The mixture of Salvia miltiorrhiza and Carthamus tinctorius (Danhong injection, DHI) is widely prescribed in China for the treatment of cardiovascular and cerebrovascular diseases. In most cases, DHI is used in combination with acetylsalicylic acid (aspirin, ASA). However, the interaction between DHI and ASA remains largely undefined. The purpose of this study is to explore the interaction profile and mechanism between DHI and ASA. The frequency of drug combination of DHI and ASA was analyzed based on 5,183 clinical cases. The interaction characteristics were evaluated by analyzing the pharmacokinetics and disposition profile of salicylic acid (SA, the primary metabolite of ASA) in rats. The interaction mechanisms were explored through evaluating the hydrolysis of ASA regulated by ASA esterase, the tubular secretion of SA mediated by influx and efflux transporters, and the tubular reabsorption of SA regulated by urinary acidity-alkalinity. The inhibitory potential of DHI on organic anion transporters (OATs) was further verified in aristolochic acid I (AAI) induced nephropathy. Clinical cases analysis showed that DHI and ASA were used in combination with high frequency of 70.73%. In drug combination of DHI and ASA, the maximum plasma concentration of SA was significantly increased by 1.37 times, while the renal excretion of SA was significantly decreased by 32.54%. The mechanism study showed that DHI significantly inhibited the transport function, gene transcription and protein expression of OATs. In OATs mediated AAI nephropathy, DHI significantly reduced the renal accumulation of AAI by 55.27%, and alleviated renal damage such as glomerulus swelling, tubular blockage and lymphocyte filtration. In drug combination of DHI and ASA, DHI increased the plasma concentration of SA not through enhancing the hydrolysis of ASA, and the tubular reabsorption of SA was not significantly affected. Inhibition of tubular secretion of SA mediated by OATs might be the reason that contributes to the decrease of SA renal excretion. Frontiers Media S.A. 2020-10-02 /pmc/articles/PMC7562828/ /pubmed/33132911 http://dx.doi.org/10.3389/fphar.2020.577012 Text en Copyright © 2020 Li, Lu, Peng, Xu, Chen, Gao, Lin, Guo and Duan http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Jianping
Lu, Jingbo
Peng, Yin
Xu, Xuejun
Chen, Chenkai
Gao, Ming
Lin, Ling
Guo, Jianming
Duan, Jinao
Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
title Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
title_full Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
title_fullStr Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
title_full_unstemmed Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
title_short Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
title_sort characteristic and mechanism of drug-herb interaction between acetylsalicylic acid and danhong injection mediated by organic anion transporters
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562828/
https://www.ncbi.nlm.nih.gov/pubmed/33132911
http://dx.doi.org/10.3389/fphar.2020.577012
work_keys_str_mv AT lijianping characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT lujingbo characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT pengyin characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT xuxuejun characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT chenchenkai characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT gaoming characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT linling characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT guojianming characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters
AT duanjinao characteristicandmechanismofdrugherbinteractionbetweenacetylsalicylicacidanddanhonginjectionmediatedbyorganicaniontransporters